Hmm! Update!
$Sangamo Therapeutics (SGMO.US)$ Pfizer/ Sangamo gene therapy for hemophilia A succeeds in late-stage trial
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Jsig1341 : Why the drop
Trytosaveabit OP Jsig1341 : Volume is still pretty low. Will have to see as other brokers open at 8-9 and MO. Plus as news circulates? GL
Jsig1341 : Thanks!!!
Trytosaveabit OP Jsig1341 : You’re welcome![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
ETWY Jsig1341 : As for safety, giroctocogene fitelparvovec was generally well tolerated among patients. However, 20% of trial participants witnessed serious adverse events, of which 13% experienced serious adverse events related to the treatment.
Although has good new，but it also not too good.
RoadToMoreMs : In at .37
Trytosaveabit OP RoadToMoreMs : GL and big profits to ya![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
RoadToMoreMs Trytosaveabit OP : Thanks to you
big appreciation
Trytosaveabit OP RoadToMoreMs : You’re welcome
annna : Thank you very much, I entered at 0.43 and exited at 0.53, so I made a little profit.
View more comments...